Logo image of TREC

Trecora Resources (TREC) Stock Fundamental Analysis

NYSE:TREC - New York Stock Exchange, Inc. - US8946481046 - Common Stock

9.81  0 (0%)

Fundamental Rating

2

Taking everything into account, TREC scores 2 out of 10 in our fundamental rating. TREC was compared to 85 industry peers in the Chemicals industry. TREC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TREC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TREC was profitable.
TREC Yearly Net Income VS EBIT VS OCF VS FCFTREC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M

1.2 Ratios

Industry RankSector Rank
ROA 3.06%
ROE 4.5%
ROIC 2.05%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TREC Yearly ROA, ROE, ROICTREC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 15

1.3 Margins

Industry RankSector Rank
OM 2.29%
PM (TTM) 2.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TREC Yearly Profit, Operating, Gross MarginsTREC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

TREC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TREC has been reduced compared to 1 year ago.
TREC has a better debt/assets ratio than last year.
TREC Yearly Shares OutstandingTREC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M
TREC Yearly Total Debt VS Total AssetsTREC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

TREC has an Altman-Z score of 3.57. This indicates that TREC is financially healthy and has little risk of bankruptcy at the moment.
TREC has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 3.57
ROIC/WACC0.18
WACC11.32%
TREC Yearly LT Debt VS Equity VS FCFTREC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 3.26 indicates that TREC has no problem at all paying its short term obligations.
TREC has a Quick Ratio of 2.51. This indicates that TREC is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 2.51
TREC Yearly Current Assets VS Current LiabilitesTREC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

TREC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 222.73%, which is quite impressive.
TREC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.48% yearly.
Looking at the last year, TREC shows a very strong growth in Revenue. The Revenue has grown by 49.80%.
The Revenue has been growing slightly by 5.12% on average over the past years.
EPS 1Y (TTM)222.73%
EPS 3Y7.02%
EPS 5Y-12.48%
EPS Q2Q%88.89%
Revenue 1Y (TTM)49.8%
Revenue growth 3Y-1.79%
Revenue growth 5Y5.12%
Sales Q2Q%52.43%

3.2 Future

Based on estimates for the next years, TREC will show a small growth in Earnings Per Share. The EPS will grow by 3.09% on average per year.
The Revenue is expected to decrease by -9.24% on average over the next years.
EPS Next Y179.15%
EPS Next 2Y67.08%
EPS Next 3Y3.09%
EPS Next 5YN/A
Revenue Next Year-25.13%
Revenue Next 2Y-15.72%
Revenue Next 3Y-9.24%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TREC Yearly Revenue VS EstimatesTREC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
TREC Yearly EPS VS EstimatesTREC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.33 indicates a quite expensive valuation of TREC.
When comparing the Price/Earnings ratio of TREC to the average of the S&P500 Index (27.45), we can say TREC is valued slightly more expensively.
The Price/Forward Earnings ratio is 23.57, which indicates a rather expensive current valuation of TREC.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, TREC is valued at the same level.
Industry RankSector Rank
PE 36.33
Fwd PE 23.57
TREC Price Earnings VS Forward Price EarningsTREC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.94
TREC Per share dataTREC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y67.08%
EPS Next 3Y3.09%

More info and screens

0

5. Dividend

5.1 Amount

TREC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Trecora Resources

NYSE:TREC (6/24/2022, 8:11:00 PM)

9.81

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-04 2022-05-04/amc
Earnings (Next)08-02 2022-08-02
Inst Owners0.06%
Inst Owner Change0%
Ins Owners12.23%
Ins Owner Change0%
Market Cap232.02M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 36.33
Fwd PE 23.57
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB N/A
EV/EBITDA 9.94
EPS(TTM)0.27
EY2.75%
EPS(NY)0.42
Fwd EY4.24%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.74
BVpS8.45
TBVpSN/A
PEG (NY)0.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.06%
ROE 4.5%
ROCE N/A
ROIC 2.05%
ROICexc N/A
ROICexgc 2.14%
OM 2.29%
PM (TTM) 2.98%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.26
Quick Ratio 2.51
Altman-Z 3.57
F-Score5
WACC11.32%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)222.73%
EPS 3Y7.02%
EPS 5Y-12.48%
EPS Q2Q%88.89%
EPS Next Y179.15%
EPS Next 2Y67.08%
EPS Next 3Y3.09%
EPS Next 5YN/A
Revenue 1Y (TTM)49.8%
Revenue growth 3Y-1.79%
Revenue growth 5Y5.12%
Sales Q2Q%52.43%
Revenue Next Year-25.13%
Revenue Next 2Y-15.72%
Revenue Next 3Y-9.24%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A